drugset / Trial / NCT00557440
Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent Asthma
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study is designed to provide data about the 24 hours FEV1 profile, safety and tolerability of indacaterol/mometasone TWISTHALER device compared to placebo and using fluticasone/salmeterol as an active control.
Timeline
- Start
- 2007-11
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone | Other / unclassified | 250 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 500 ug | Inhaled |
| Subject | Mometasone | Other / unclassified | 400 ug | Inhaled |
| Subject | Salmeterol | Other / unclassified | 50 ug | Inhaled |